Skip to main navigation
Skip to search
Skip to main content
Research Nebraska Home
Help & FAQ
Home
Profiles
Research units
Facilities and Equipment
Research output
Projects
Activities
Prizes
Search by expertise, name or affiliation
Contact Expert
View Scopus Profile
Ran Dai, PhD
Assistant Professor
,
Biostatistics
Phone
402-559-2409
h-index
328
Citations
10
h-index
Calculated based on number of publications stored in Pure and citations from Scopus
2014
2025
Research activity per year
Overview
Fingerprint
Network
Research output
(28)
Similar Profiles
(6)
Fingerprint
Dive into the research topics where Ran Dai is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Acute Kidney Injury
10%
Adverse Cardiac Events
31%
Aryl Hydrazide
16%
Arylhydrazines
16%
Biotin Biosynthesis
16%
Breakthrough SARS-CoV-2 Infection
16%
Conformational Diversity
8%
Coronavirus Disease (COVID)
58%
COVID-19
71%
COVID-19 Outcomes
16%
Data Generating Process
8%
Death Assemblages
16%
Differential Scanning Fluorimetry
8%
Electron FLASH
16%
Electronic Health Records
16%
FDR Control
16%
Group Sparse Regression
16%
Heavy-tailed Data
8%
High-dimensional Covariates
16%
Hormone Replacement Therapy
16%
Immunosuppressed
11%
Knockoff Filter
16%
Major Adverse Renal Events
44%
Mixed Layer
16%
Multi-task Regression
16%
Mycobacterium Tuberculosis (M. tb)
16%
Organ-specific
16%
Positive Unlabelled
11%
Post-acute Sequelae
16%
Post-COVID-19
8%
Post-transplant Diabetes Mellitus
16%
Pyridoxal 5′-phosphate
8%
Quality Payment Program
16%
Quinonoid
8%
Refitted Cross-validation
8%
Rural-urban
16%
Sectional Analysis
16%
Sex-specific
16%
Single-index Model
16%
Solid Organ Transplant
25%
Solid Organ Transplant Recipients
65%
Solid Organ Transplantation
33%
Specific Risk
16%
Survival Extrapolation
16%
Therapeutic Intervention
8%
Transaminases
16%
Tuberculosis
12%
United States
7%
Whole Cell Activity
11%
X-ray Crystal Structure
8%
Medicine and Dentistry
Acute Kidney Injury
12%
Allograft
8%
Cell Size
8%
COVID-19
100%
Cross Sectional Study
16%
Drug Megadose
16%
Electronic Health Record
16%
Graft Failure
8%
Immunocompromised Patient
12%
Ionization Chamber
8%
Isocenter
8%
Kidney Graft
11%
Logistic Regression Analysis
7%
Malignant Neoplasm
8%
Prevalence
16%
Propensity Score Matching
6%
Pulse Rate
16%
Radiation Therapy
8%
Sequela
16%
Solid Organ Transplantation
50%
Therapeutic Window
8%
Transplantation
85%
